Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Costello

Showing results (301-310 of 368) with videos related to

Pageof 37
Sort By:
Nature Methods|December 1, 2011
The Human Epigenome Browser at Washington UniversityXin Zhou, Brett Maricque, Mingchao Xie, et al.
Cancer Research|October 3, 2008
Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumorsJoo Mi Yi, Hsing-Chen Tsai, Sabine C Glöckner, et al.
Cancer Discovery|February 1, 2015
The genetics of splicing in neuroblastomaJustin Chen, Christopher S Hackett, Shile Zhang, et al.
The Medical Journal of Australia|November 21, 2018
Translation and implementation of the Australian-led PCOS guideline: clinical summary and translation resources from the International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary SyndromeHelena J Teede, Marie L Misso, Jacqueline A Boyle, et al.
Molecular Cell|June 13, 2025
The immortality mechanism of TERT promoter mutant cancers is self-reinforcing and reversibleNicholas O Stevers, Somang Kim, Jimmy Bo Yuan, et al.
Oncogene|August 6, 2013
Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma developmentC Dutruel, F Bergmann, I Rooman, et al.
Science (New York, N.Y.)|May 16, 2015
Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancerRobert J A Bell, H Tomas Rube, Alex Kreig, et al.
Cancer Research|November 5, 2016
Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation ProcessShigeo Ohba, Joydeep Mukherjee, Tor-Christian Johannessen, et al.
IEEE Transactions on Medical Imaging|August 4, 2025
In vivo 4D x-ray dark-field lung imaging in miceYing Ying How, Nicole Reyne, Michelle K Croughan, et al.
Neuro-Oncology|September 8, 2011
Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcomaNicholas Butowski, Susan M Chang, Kathleen R Lamborn, et al.
Pageof 37

Showing results (301-310 of 368) with videos related to

Sort By:
Pageof 37
Nature Methods|December 1, 2011
The Human Epigenome Browser at Washington UniversityXin Zhou, Brett Maricque, Mingchao Xie, et al.
Cancer Research|October 3, 2008
Abnormal DNA methylation of CD133 in colorectal and glioblastoma tumorsJoo Mi Yi, Hsing-Chen Tsai, Sabine C Glöckner, et al.
Cancer Discovery|February 1, 2015
The genetics of splicing in neuroblastomaJustin Chen, Christopher S Hackett, Shile Zhang, et al.
The Medical Journal of Australia|November 21, 2018
Translation and implementation of the Australian-led PCOS guideline: clinical summary and translation resources from the International Evidence-based Guideline for the Assessment and Management of Polycystic Ovary SyndromeHelena J Teede, Marie L Misso, Jacqueline A Boyle, et al.
Molecular Cell|June 13, 2025
The immortality mechanism of TERT promoter mutant cancers is self-reinforcing and reversibleNicholas O Stevers, Somang Kim, Jimmy Bo Yuan, et al.
Oncogene|August 6, 2013
Early epigenetic downregulation of WNK2 kinase during pancreatic ductal adenocarcinoma developmentC Dutruel, F Bergmann, I Rooman, et al.
Science (New York, N.Y.)|May 16, 2015
Cancer. The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancerRobert J A Bell, H Tomas Rube, Alex Kreig, et al.
Cancer Research|November 5, 2016
Mutant IDH1 Expression Drives TERT Promoter Reactivation as Part of the Cellular Transformation ProcessShigeo Ohba, Joydeep Mukherjee, Tor-Christian Johannessen, et al.
IEEE Transactions on Medical Imaging|August 4, 2025
In vivo 4D x-ray dark-field lung imaging in miceYing Ying How, Nicole Reyne, Michelle K Croughan, et al.
Neuro-Oncology|September 8, 2011
Phase II and pharmacogenomics study of enzastaurin plus temozolomide during and following radiation therapy in patients with newly diagnosed glioblastoma multiforme and gliosarcomaNicholas Butowski, Susan M Chang, Kathleen R Lamborn, et al.
Pageof 37